Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

334
In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
334
Acute Pyelonephritis II: Diagnostic Studies and Management01:28

Acute Pyelonephritis II: Diagnostic Studies and Management

532
Introduction:For diagnosing acute pyelonephritis, a comprehensive patient history is collected to identify symptoms such as dysuria, frequent or urgent urination, flank pain, or costovertebral angle (CVA) tenderness that may suggest a kidney infection.Physical ExaminationDuring the physical examination, CVA tenderness is assessed. This involves gentle percussion over the costovertebral angle, where tenderness often indicates a kidney infection.Diagnostic TestsUrinalysis: Used to identify white...
532
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

381
Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
381
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

377
Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
377
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

289
In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
289
Pneumonia I: Introduction01:30

Pneumonia I: Introduction

1.1K
Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
1.1K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

COVID-19 and hereditary spherocytosis: A recipe for hemolysis.

Pediatric blood & cancer·2020
Same author

Case 2: Red Toes in a 17-day-old Boy.

Pediatrics in review·2018
Same author

Pediatric Hospital Medicine.

Pediatric annals·2017
See all related articles

Related Experiment Video

Updated: Feb 26, 2026

Subcutaneous Infection of Methicillin Resistant Staphylococcus Aureus MRSA
12:18

Subcutaneous Infection of Methicillin Resistant Staphylococcus Aureus MRSA

Published on: February 9, 2011

23.7K

Pediatric Cellulitis: A Red-Hot Concern.

Andrew Shriner, Laurie Wilkie

    Pediatric Annals
    |July 12, 2017
    PubMed
    Summary
    This summary is machine-generated.

    Pediatric cellulitis, a common bacterial skin infection, often requires prompt diagnosis and treatment. While most children recover, some need hospitalization, highlighting the need for effective antibiotic strategies.

    More Related Videos

    Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria
    11:32

    Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria

    Published on: February 23, 2014

    15.7K
    A Neonatal Imaging Model of Gram-Negative Bacterial Sepsis
    08:46

    A Neonatal Imaging Model of Gram-Negative Bacterial Sepsis

    Published on: August 12, 2020

    7.0K

    Related Experiment Videos

    Last Updated: Feb 26, 2026

    Subcutaneous Infection of Methicillin Resistant Staphylococcus Aureus MRSA
    12:18

    Subcutaneous Infection of Methicillin Resistant Staphylococcus Aureus MRSA

    Published on: February 9, 2011

    23.7K
    Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria
    11:32

    Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria

    Published on: February 23, 2014

    15.7K
    A Neonatal Imaging Model of Gram-Negative Bacterial Sepsis
    08:46

    A Neonatal Imaging Model of Gram-Negative Bacterial Sepsis

    Published on: August 12, 2020

    7.0K

    Area of Science:

    • Pediatrics
    • Infectious Diseases
    • Dermatology

    Background:

    • Cellulitis and other skin and soft tissue infections are frequent reasons for pediatric healthcare visits.
    • Bacterial infections, primarily streptococci or Staphylococcus aureus, cause cellulitis.
    • While most children recover, a subset requires hospitalization.

    Purpose of the Study:

    • To review the diagnosis and management of pediatric cellulitis.
    • To emphasize the importance of recognizing when inpatient treatment is necessary.
    • To discuss challenges in diagnosis and the variability in current management.

    Main Methods:

    • Literature review and clinical expertise synthesis.
    • Discussion of diagnostic criteria for cellulitis.
    • Analysis of treatment approaches and antibiotic selection.

    Main Results:

    • Diagnosis can be challenging, requiring differentiation from more serious conditions.
    • Management strategies are variable, with a need for standardized approaches.
    • The goal of treatment is clinical improvement using narrow-spectrum antibiotics for the shortest effective duration.

    Conclusions:

    • Skilled diagnosis and appropriate treatment are crucial for pediatric cellulitis.
    • Further research is needed to establish optimal treatment regimens.
    • Narrow-spectrum antibiotics for the shortest necessary duration are recommended.